Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-14.94T
↓ 124% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
$-6.68T
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-14.94T | +71.2% |
| 2025 | $-51.83T | -75340109.9% |
| 2024 | $-68.79M | -60.1% |
| 2023 | $-42.97M | +24.2% |
| 2022 | $-56.67M | -4.5% |
| 2021 | $-54.25M | -70.7% |
| 2020 | $-31.79M | +2.9% |
| 2019 | $-32.73M | +8.6% |
| 2018 | $-35.82M | -126.8% |
| 2017 | $-15.80M | - |